03 Profile
Vital Signsby Bridgehead
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
David Margolin: no licensed photograph is held, so the academic plate is shown instead.
Academic
David Margolin
M.D., Ph.D., VP of clinical development at uniQure
1
0
0
0
0
0
0
0
Apr 2026MayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 17 Apr 2026 · last quoted 17 Apr 2026
02 Quoted on · 1 of 29 topics
David Margolin: key facts
- Kind of voice
- Academic
- Role
- M.D., Ph.D., VP of clinical development at uniQure
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 17 Apr 2026
04 The signal · where David Margolin sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Dr Jayne HoughtonAcademiclead Clinical Scientist for this project at the Royal Devon University Healthcare NHS Foundation Trust1
- 25=Professor Sarah FlanaganAcademicProfessor of the University of Exeter Medical School1
- 25=David MargolinAcademicM.D., Ph.D., VP of clinical development at uniQure1
- 25=Kelley KidwellAcademicPh.D., University of Michigan biostatistician1
- 25=Susana ZaphAcademicPh.D., U.S. head of QSP at Sanofi1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What David Margolin has said
By outlet · linked articles
- fiercebiotech.com1
Where David Margolin has been quoted
- 01Small pools, big ideas: How the rare disease community is reimagining clinical trialsfiercebiotech.com · 17 Apr 2026
Verbatim
“I know there's active dialogue with FDA and the Huntington's disease organizations regarding how to interpret and best utilize these clinical scored measures, and that's an ongoing process”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.